Premium
Interventions for the Management of Denture Stomatitis: A Systematic Review and Meta‐Analysis
Author(s) -
Hilgert Juliana Balbinot,
Giordani Jessye Melgarejo do Amaral,
Souza Raphael Freitas,
Wendland Eliana Márcia Da Ros,
D'Avila Otavio Pereira,
Hugo Fernando Neves
Publication year - 2016
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/jgs.14399
Subject(s) - medicine , psychological intervention , meta analysis , stomatitis , medline , dentistry , intensive care medicine , nursing , dermatology , pathology , political science , law
Objectives To assess the effectiveness of different interventions for treating or preventing denture stomatitis ( DS ). Design Systematic review. Setting Randomized controlled trials ( RCT s) comparing any agent or procedure prescribed to treat or prevent DS in adults. Participants Older adults with denture stomatitis. Measurements There were two main outcomes reported in the trials included in this review: clinical signs of DS and remaining presence of yeast. There were no restrictions regarding language or date of publication. The search period was up to February 2016. Results Thirty‐five studies were included in the systematic review, with 32 judged as having high risk of bias. Three RCT s compared nystatin with placebo and found a significant effect on the reduction of clinical signs of stomatitis (risk ratio ( RR ) = 0.51, 95% confidence interval ( CI ) = 0.36–0.72), four RCT s compared nystatin with placebo and found a significant effect on mycological assessment ( RR = 0.61, 95% CI = 0.46–0.80). Five studies of disinfectant agents also showed a significant effect in comparison with an inactive agent ( RR = 0.52, 95% CI = 0.30–0.92) in clinical assessment. No evidence was found of an effect of miconazole, amphotericin, or imidazolic drugs. No RCT evaluated the effectiveness of preventive approaches. Conclusion The results are supportive of the use of nystatin and disinfecting agents in the treatment of DS , but clinicians need to be aware that individual studies had high risk of bias and that the overall quality of the individual reports was judged to be low.